Brief: INmune Bio Reports EEG Improvement In Alzheimer’s Patients Treated with XPro
March 5 (Reuters) - INmune Bio Inc INMB.O :
* INMUNE BIO REPORTS SIGNIFICANT EEG IMPROVEMENT IN
ALZHEIMER’S
PATIENTS TREATED WITH XPRO™
* INMUNE BIO- PATIENTS WHO GOT WEEKLY XPRO™ TREATMENT FOR
FOUR
WEEKS HAD STATISTICALLY SIGNIFICANT INCREASE IN ALPHA WAVE
FREQUENCY & POWER
Source text for Eikon: ID:nGNX2j8DLJ
Further company coverage: INMB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inmune Bio
See all newsBrief: Inmune Bio - Enters Master Services Agreement With Uniphar For Ebstrocel International Commercialization
Brief: Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027
INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary
INmune Bio Q2 net loss narrows on lower impairment charges
INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview